Redwave Syndrome

Redwave Syndrome is a severe and highly destabilising engineered infectious disease first identified on W9, later spreading to New Mald. It represents the clearest confirmed case of deliberate pathogen engineering encountered by the Quadrant Health Organisation (QHO) to date and is widely regarded as a turning point in Quadrant 7 biosecurity policy.

Clinically, Redwave Syndrome presents with high fever, acute systemic inflammation, and pronounced neurological impairment, including disorientation, motor dysfunction, and cognitive disturbance. As the disease progresses, patients experience vascular stress, multi-organ involvement, and rapid physiological collapse. Untreated cases frequently deteriorate within days, overwhelming local medical services.

Genomic analysis conducted by the Quadrant Health Organisation, in liaison with intelligence partners, confirmed that Redwave exhibits non-natural genetic splice patterns and optimisation for transmissibility and persistence. Comparative studies linked it to a wider cluster of pathogens sharing common design features, strongly indicating coordinated development rather than isolated experimentation.

The outbreak on W9 prompted large-scale humanitarian intervention, emergency medical deployment, and strict containment measures. Subsequent spread to New Mald was exacerbated by political instability and degraded public health infrastructure.

Redwave Syndrome directly drove the development of cross-pathogen antiviral agents, which entered human trials and controlled deployment in later turns. Within QHO doctrine, Redwave is classified as a strategic biosecurity threat, demonstrating the feasibility of engineered disease as a tool of coercion, destabilisation, and asymmetric conflict in Quadrant 7.